Prostatype® – a new gene test for prostate cancer patients


Vision & Mission


Our vision is that doctors and patients, confronted with diagnosed prostate cancer, have full confidence in their treatment decisions.

Chundsell Medicals’ mission is to make a difference in prostate cancer patients’ lives through the discovery and commercialization of transformative tests to guide treatment decisions. We can thereby increase quality of life and peace-of-mind for patients and simultaneously reduce health care costs. Chundsell Medicals will achieve this by making PrTS the global test system of choice for newly diagnosed prostate cancer patients.